Algernon Pharmaceuticals (OTCMKTS:AGNPF) Trading Down 1.3% – Should You Sell?

Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF – Get Free Report) was down 1.3% during mid-day trading on Monday . The stock traded as low as $0.30 and last traded at $0.3254. 650 shares traded hands during trading, a decline of 92% from the average daily volume of 8,568 shares. The stock had previously closed at $0.3296.

Algernon Pharmaceuticals Stock Down 1.3%

The business’s fifty day simple moving average is $0.31 and its 200 day simple moving average is $0.19.

About Algernon Pharmaceuticals

(Get Free Report)

Algernon Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel, small-molecule therapeutics. The company’s primary strategy centers on repurposing known compounds with established safety profiles to address unmet medical needs, particularly in the realms of pulmonary fibrosis, acute lung injury and central nervous system (CNS) disorders. By leveraging existing pharmacology data, Algernon aims to accelerate its development timelines while managing costs and risks typically associated with early-stage drug discovery.

The lead asset in Algernon’s pipeline is NP-120 (ifenprodil), an orally available small molecule being investigated for idiopathic pulmonary fibrosis (IPF).

Further Reading

• Five stocks we like better than Algernon Pharmaceuticals
• Commodities Are Booming, But These 3 ETFs Tell Different Stories
• 3 Active ETFs Making Big Moves in August
• This ETF Is Outperforming by Avoiding the S&P 500’s Biggest Problem
• Birkenstock Beats the Skeptics—But Not on EPS